Newsroom Investors Who We Are Businesses NASDAQ: NVOS Innovations in Research & Diagnostics Oncology Highlight At Acenzia, we have developed a ground-breaking, patented technology to predict metastasis & support optimal therapeutic decisions. Read More... Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved

Newsroom Investors Who We Are Businesses NASDAQ: NVOS Our People Company Leadership NVOS Leadership Team Robert Mattacchione Board Chairman & CEO Chris David COO/President James Zsebok NVOS Principal Financial Officer (PFO), NHL Vice President Finance Indrajit Sinha Chief Science Officer (CSO) Novo Healthnet Limited (NHL) Leadership Team James Asher President Dr Thomas Barus NHL EVP, Technology Christopher Wade NHL EVP, Strategy & Operations James Zsebok NVOS Principal Financial Officer (PFO), NHL Vice President Finance Stay connected with Investor news Follow us and stay up to date on what's happening at Novo Integrated Sciences CAUTION CONCERNING FORWARD LOOKING STATEMENTS Novo Integrated Sciences's Investor Relations website at www.novointegrated.com/investors and our corporate blog at novointegrated.com/newsroom as well as Novo Integrated Sciences's social media accounts, contain a significant amount of information about the company, including financial and other information for investors. Novo Integrated Sciences encourages investors to visit these websites from time to time, as information is updated and new information is posted. ROBERT MATTACCHIONE CEO, Novo Integrated Sciences Inc Follow Robert on LinkedIn CHRIS DAVID President, Novo Integrated Sciences Inc Follow Chris on LinkedIn Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved